Axonics Inc. - AXNX Net earnings per one share for the last twelve months

Axonics Inc. (AXNX) - corporate logo

The history of net income per share growth YoY ttm reflects the dynamics of Axonics, Inc. (AXNX), where the current level is approximately -549.10. Incontinence treatment solutions are moderately resilient to cycles, although the elective nature of procedures may slow sales during a recession. Insurance reimbursement provides stability, while outsourcing chip production to external foundries minimizes capital expenditures.

AXNX: axonics.com Net earnings per share for the last 12 months 02/11/2024 - 11/15/2026

Axonics Inc. - analytical breakdowns and key metrics (AXNX)

- stock quotes and analyst forecast:
Quote Chart Axonics|AXNX - Analyst Consensus Forecast
- issuer market value details:
Market Value Axonics Modulation Technologies|AXNX - Enterprise Value
- company book value details:
Equity per Share Axonics|AXNX - Company Net Assets|Market Value to Book Value axonics.com|AXNX - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Axonics, Inc.|AXNX - Long-Term Debt to Capital|Current Liabilities to Capital Axonics, Inc.|AXNX - Company Aggregate Debts|Debt to Book Value Ratio Axonics Modulation Technologies|AXNX - Company Long-Term Debts|Short-Term Debt Volume Axonics|Quick Liquidity Indicator axonics.com
- earnings and valuation multiples information:
AXNX - Net Profit|Projected Future Earnings Axonics, Inc.|AXNX - Price to Earnings Ratio|Future Price to Earnings Axonics, Inc.|AXNX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Axonics Modulation Technologies|AXNX - Operating profit EBITDA|Net earnings per one share for the last twelve months Axonics|AXNX - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year axonics.com|AXNX - Net earnings per share growth this year|Earnings growth forecast for next year Axonics, Inc.
- sales volume and revenue information:
AXNX - Revenue and Sales Volume|Company Future Sales Axonics Inc.|AXNX - Price-to-Revenue Ratio|Future Price to Revenue Axonics, Inc
Fundamental company valuation:Axonics, AXNX
Manufactured product of Axonics

Investors must find a balance between operational risks and the actual return on invested capital. Axonics, Inc. (AXNX) dominates the bladder treatment segment thanks to its unique wireless charging technologies. The current annual EPS TTM growth rate measures the net income per share dynamics over a rolling year. This momentum confirms the effectiveness of monetizing its technological advantage over competitors. The steady growth of this metric indicates high business resilience.

Competitor analysis for Axonics, Inc.

Net earnings per one share for the last twelve months Boston Scientific Corporation|EW (Edwards Lifesciences Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months RMD|PODD (Insulet) - Net earnings per share (EPS TTM)|ZBH: Earnings per share for the trailing year|Earnings per share for the last twelve months The Cooper Companies, Inc. (COO)|ALGN (Invisalign) - Earnings per share for the trailing year|Earnings per share for the last twelve months NuVasive GMED|TMDX - Net earnings per share for the last 12 months|Alphatec Holdings - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Artivion, Inc.|ENOV: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months IART|ESTA (Establishment Labs Inc) - Net earnings per share (EPS TTM)|Beta Bionics Corp (BBNX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) IRMD|Net earnings per share for the last 12 months Embecta Corp. EMBC|Net earnings per share (EPS TTM) TNDM (tandemdiabetes.com)|Net earnings per share (EPS TTM) AxoGen Inc AXGN|SIBN - Earnings per share for the last twelve months|OFIX: Earnings per share for the last twelve months|BVS: Net earnings per share (EPS TTM)|OrthoPediatrics Corp - Earnings per share for the trailing year|TMCI (Treace Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Blade Air Mobility SRTA|Earnings per share for the last twelve months Carlsmed, Inc. (CARL)|RxSight, Inc. (RXST) - Net earnings per share for the trailing year|ClearPoint Neuro Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Stereotaxis, Inc. STXS|Neuronetics Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Sight Sciences Inc. SGHT|Orchestra BioMed, Inc. (OBIO) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ANIK (Anika)|Earnings per share for the last twelve months inspiremd.com|Net earnings per share for the last 12 months Jin Medical International (ZJYL)|Net earnings per share (EPS TTM) VANI|XTNT - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months NeuroOne Medical Technologies NMTC|MODD: Earnings per share for the last 12 months|MYO - Earnings per share for the last twelve months|Envoy Medical, Inc. - Earnings per share for the last four quarters|VVOS (Vivos Therapeutics, Inc.) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months enVVeno Medical Corporation (NVNO)|SINT (Sintx Technologies, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Tenon Medical Inc TNON|Net earnings per share for the last 12 months LFWD (rewalk.com)|Earnings per share for the last four quarters AMIX|INVO Fertility - Net earnings per share for the last 12 months|Bone Biologics Corporation (BBLG) - Net earnings per one share for the last twelve months|BIOLASE Inc. - Net earnings per share (EPS TTM)|Dynatronics - Earnings per share for the last four quarters|Paragon 28, Inc. (FNA) - Earnings per share for the last twelve months|INVO (INVO Bioscience Inc.) - Earnings per share for the last twelve months